Cardiac pathologies in relation to Smad-dependent pathways

Interactive Cardiovascular and Thoracic Surgery

Volumn 11, Issue 4, 2010, Pages 455-460

  Yuan, Shi Min ^a   Jing, Hua ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Bone morphogenetic proteins; Cardiac diseases; Map kinase signaling system; Signal transduction; Smad proteins; Transforming growth factor b

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CD36 ANTIGEN; LOSARTAN; MITOGEN ACTIVATED PROTEIN KINASE; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

AORTA DISEASE; ARTICLE; ATHEROSCLEROSIS; DISEASE ASSOCIATION; ENZYME ACTIVITY; HEART DEVELOPMENT; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HUMAN; MARFAN SYNDROME; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PULMONARY HYPERTENSION; RISK FACTOR; SIGNAL TRANSDUCTION;

BONE MORPHOGENETIC PROTEINS; CARDIOVASCULAR DISEASES; HUMANS; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 78249248682     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2010.234773     Document Type: Article

References (51)

1. Chen YG, Meng AM. Negative regulation of TGF-b signaling in development. Cell Res 2004;14:441-449.
2. Miyazawa K, Shinozaki M, Hara T, Furuya T, Miyazono K. Two major Smad pathways in TGF-b superfamily signaling. Genes Cells 2002; 7:1191-1204.
3. Gordon KJ, Blobe GC. Role of transforming growth factor-b superfamily signaling pathways in human disease. Biochim Biophys Acta 2008; 1782:197-228.
4. Kawabata M, Miyazono K. Signal transduction of the TGF-b superfamily by Smad proteins. J Biochem 1999;125:9-16.
5. Goumans MJ, Valdimarsdottir G, Itoh S, Lebrin F, Larsson J, Mummery C, Karlsson S, ten Dijke P. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbyALK5 signaling. Mol Cell 2003;12:817-828.
6. Li TS, Komota T, Ohshima M, Qin SL, Kubo M, Ueda K, Hamano K. TGF-b induces the differentiation of bone marrow stem cells into immature cardiomyocytes. Biochem Biophys Res Commun 2008;366:1074-1080.
7. Miyazono K, Maeda S, Imamura T. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev 2005;16:251-263.
8. Massagué J. TGF-b signal transduction. Annu Rev Biochem 1998;67:753-791.
9. Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. Growth Factors 2004;22:233-241.
10. Nishimura R, Kato Y, Chen D, Harris SE, Mundy GR, Yoneda T. Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12. J Biol Chem 1998;273:1872-1879.
11. Izumi M, Masaki M, Hiramoto Y, Sugiyama S, Kuroda T, Terai K, Hori M, Kawase I, Hirota H. Cross-talk between bone morphogenetic protein 2 and leukemia inhibitory factor through ERK 1y2 and Smad1 in protection against doxorubicin-induced injury of cardiomyocytes. J Mol Cell Cardiol 2006;40:224-233.
12. Kawabata M, Imamura T, Miyazano K. Signal transduction by bone morphogenetic proteins. Cytokine Growth Factor Rev 1998;9:49-61.
13. Nohe A, Keating E, Knaus P, Petersen NO. Signal transduction of bone morphogenetic protein receptors. Cell Signal 2004;16:291-299.
14. Kretzschmar M, Doody J, Massagué J. Opposing BMP and EGF signaling pathways converge on the TGF-b family mediator Smad1. Nature 1997;389:618-622.
15. Bakin AV, Rinehart C, Tomlinson AK, Arteaga CL. p38 mitogen-activated protein kinase is required for TGFb-mediated fibroblastic trans differentiation and cell migration. J Cell Sci 2002;115(Pt 15):3193-3206.
16. Verheyen EM. Opposing effects of Wnt and MAPK on BMPySmad signal duration. Dev Cell 2007;13:755-756.
17. Heger J, Peters SC, Piper HM, Euler G. SMAD-proteins as a molecular switch from hypertrophy to apoptosis induction in adult ventricular cardiomyocytes. J Cell Physiol 2009;220:515-523.
18. Sakata Y, Chancey AL, Divakaran VG, Sekiguchi K, Sivasubramanian N, Mann DL. Transforming growth factor-b receptor antagonism attenuates myocardial fibrosis in mice with cardiac-restricted overexpression of tumor necrosis factor. Basic Res Cardiol 2008;103:60-68.
19. Schneiders D, Heger J, Best P, Michael Piper H, Taimor G. SMAD proteins are involved in apoptosis induction in ventricular cardiomyocytes.
20. Cardiovasc Res 2005;67:87-96.
21. Xu J, Kimball TR, Lorenz JN, Brown DA, Bauskin AR, Klevitsky R, Hewett TE, Breit SN, Molkentin JD. GDF15yMIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation. Circ Res 2006;98:342-350.
22. Kania G, Blyszczuk P, Stein S, Valaperti A, Germano D, Dirnhofer S, Hunziker L, Matter CM, Eriksson U. Heart-infiltrating prominin-1qy CD133q progenitor cells represent the cellular source of transforming growth factor b-mediated cardiac fibrosis in experimental autoimmune myocarditis. Circ Res 2009;105:462-470.
23. Zhu XY, Daghini E, Rodriguez-Porcel M, Chade AR, Napoli C, Lerman A, Lerman LO. Redox-sensitive myocardial remodeling and dysfunction in swine diet-induced experimental hypercholesterolemia. Atherosclerosis 2007;193:62-69.
24. Xia Y, Lee K, Li N, Corbett D, Mendoza L, Frangogiannis NG. Characterization of the inflammatory and fibrotic response in a mouse model of cardiac pressure overload. Histochem Cell Biol 2009;131:471-481.
25. Zhao XY, Zhao LY, Zheng QS, Su JL, Guan H, Shang FJ, Niu XL, He YP, Lu XL. Chymase induces profibrotic response via transforming growth factor-b1ySmad activation in rat cardiac fibroblasts. Mol Cell Biochem 2008;310:159-166.
26. Divakaran V, Adrogue J, Ishiyama M, Entman ML, Haudek S, Sivasubramanian N, Mann DL. Adaptive and maladaptive effects of SMAD3 signaling in the adult heart after hemodynamic pressure overloading. Circ Heart Fail 2009;2:633-642.
27. Cucoranu I, Clempus R, Dikalova A, Phelan PJ, Ariyan S, Dikalov S, Sorescu D. NAD(P)H oxidase 4 mediates transforming growth factor-b1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ Res 2005;97:900-907.
28. [27] Gramley F, Lorenzen J, Koellensperger E, Kettering K, Weiss C, Munzel T. Atrial fibrosis and atrial fibrillation: the role of the TGF-b1 signaling pathway. Int J Cardiol 2009 Apr 23. wEpub ahead of printx.
29. Margaron Y, Bostan L, Exposito JY, Malbouyres M, Trunfio-Sfarghiu AM, Berthier Y, Lethias C. Tenascin-X increases the stiffness of collagen gels without affecting fibrillogenesis. Biophys Chem 2010;147:87-91.
30. Pearson CA, Pearson D, Shibahara S, Hofsteenge J, Chiquet-Ehrismann R. Tenascin: cDNA cloning and induction by TGF-b. EMBO J 1988;7:2977-2982.
31. Dadlani H, Ballinger ML, Osman N, Getachew R, Little PJ. Smad and p38 MAP kinase-mediated signaling of proteoglycan synthesis in vascular smooth muscle. J Biol Chem 2008;283:7844-7852.
32. Khanna AK. Enhanced susceptibility of cyclin kinase inhibitor p21 knockout mice to high fat diet induced atherosclerosis. J Biomed Sci 2009;16:66.
33. Topper JN, Cai J, Qiu Y, Anderson KR, Xu YY, Deeds JD, Feeley R, Gimeno CJ, Woolf EA, Tayber O, Mays GG, Sampson BA, Schoen FJ, Gimbrone MA Jr, Falb D. Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium. Proc Natl Acad Sci USA 1997;94:9314-9319.
34. Mallat Z, Gojova A, Marchiol-Fournigault C, Esposito B, Kamaté C, Merval R, Fradelizi D, Tedgui A. Inhibition of transforming growth factor-b signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ Res 2001;89:930-934.
35. Hao J, Wang B, Jones SC, Jassal DS, Dixon IM. Interaction between angiotensin II and Smad proteins in fibroblasts in failing heart and in vitro. Am J Physiol Heart Circ Physiol 2000;279:H3020-3030.
36. Masaki M, Izumi M, Oshima Y, Nakaoka Y, Kuroda T, Kimura R, Sugiyama S, Terai K, Kitakaze M, Yamauchi-Takihara K, Kawase I, Hirota H. Smad1 protects cardiomyocytes from ischemia-reperfusion injury. Circulation 2005;111:2752-2759.
37. Euler-Taimor G, Heger J. The complex pattern of SMAD signaling in the cardiovascular system. Cardiovasc Res 2006;69:15-25.
38. Maleszewski JJ, Miller DV, Lu J, Dietz HC, Halushka MK. Histopathologic findings in ascending aortas from individuals with Loeys-Dietz syndrome (LDS). Am J Surg Pathol 2009;33:194-201.
39. Dong C, Zhu S, Yoon W, Wang T, Alvarez RJ, Goldschmidt-Clermont PJ. Upregulation of PAI-1 is mediated through TGF bySMAD pathway in transplant arteriopathy. J Heart Lung Transplant 2001;20:219.
40. Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK, Myers L, Klein EC, Liu G, Calvi C, Podowski M, Neptune ER, Halushka MK, Bedja D, Gabrielson K, Rifkin DB, Carta L, Ramirez F, Huso DL, Dietz HC. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 2006;312:117-121.
41. Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys B, Cooper TK, Myers L, Klein EC, Liu G, Calvi C, Podowski M, Neptune ER, Halushka MK, Bedja D, Gabrielson K, Rifkin DB, Carta L, Ramirez F, Huso DL, Dietz HC. Losartan in Marfan syndrome-beyond blood pressure lowering. J Am Soc Nephrol 2006;17:1759-1764.
42. Yuan JX, Rubin LJ. Pathogenesis of pulmonary arterial hypertension: the need for multiple hits. Circulation 2005;111:534-538.
43. West J. Cross talk between Smad, MAPK and actin in the etiology of pulmonary arterial hypertension. Adv Exp Med Biol 2010;661:265-278.
44. Pal R, Khanna A. Role of smadand wnt-dependent pathways in embryonic cardiac development. Stem Cells Dev 2006;15:29-39.
45. Yamada M, Szendro PI, Prokscha A, Schwartz RJ, Eichele G. Evidence for a role of Smad6 in chick cardiac development. Dev Biol 1999;215:48-61.
46. Chen Q, Chen H, Zheng D, Kuang C, Fang H, Zou B, Zhu W, Bu G, Jin T, Wang Z, Zhang X, Chen J, Field LJ, Rubart M, Shou W, Chen Y. Smad7 is required for the development and function of the heart. J Biol Chem 2009;284:292-300.
47. Kiyono K, Suzuki HI, Morishita Y, Komuro A, Iwata C, Yashiro M, Hirakawa K, Kano MR, Miyazono K. c-Ski overexpression promotes tumor growth and angiogenesis through inhibition of transforming growth factor-b signaling in diffuse-type gastric carcinoma. Cancer Sci 2009;100:1809-1816.
48. Cushing MC, Mariner PD, Liao JT, Sims EA, Anseth KS. Fibroblast growth factor represses Smad-mediated myofibroblast activation in aortic valvular interstitial cells. FASEB J 2008;22:1769-1777.
49. Ruiz-Ortega M, Rodríguez-Vita J, Sanchez-Lopez E, Carvajal G, Egido J. TGF-b signaling in vascular fibrosis. Cardiovasc Res 2007;74:196-206.
50. Li P, Wang D, Lucas J, Oparil S, Xing D, Cao X, Novak L, Renfrow MB, Chen YF. Atrial natriuretic peptide inhibits transforming growth factor b-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts. Circ Res 2008;102:185-192.
51. [Nguyen BK, Maltais S, Perrault LP, Tanguay JF, Tardif JC, Stevens LM, Borie M, Harel F, Mansour S, Noiseux N. Improved function and myocardial repair of infarcted heart by intracoronary injection of mesenchymal stem cell-derived growth factors. J Cardiovasc Transl Res 2010;3:547-558.